alexa Adjuvant Chemoradiation for Localized Gastric Adenocarcinoma: An Institutional Experience
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Adjuvant Chemoradiation for Localized Gastric Adenocarcinoma: An Institutional Experience

Asmae Touil1, Hasnaa Loughlimi1*, Sarah El Abbassi1, Yassine Echchikhi1, Samir Ahid2 Karam Yatribi1, Sanaa El Majjaoui1, Hanane El Kacemi1, Tayeb Kebdani1, and Nourredine Benjafaar1

1Department of Radiation Oncology, National Institute of Oncology, Mohamed V University in Rabat, Morocco

2Department of Public Health, Laboratory of Biostatics, Clinical Research and Epidemiology, Mohamed V University in Rabat, Morocco

*Corresponding Author:
Hasnaa Loughlimi
Department of Radiation Oncology
National Institute of Oncology, Mohamed V University in Rabat,
Morocco
Tel: 212661696335
E-mail: [email protected]

Received date: April 26, 2017; Accepted date: May 17, 2017; Published date: May 19, 2017

Citation: Touil A, Loughlimi H, Abbassi SEl, Echchikhi Y, Yatribi SAK, et al. (2017) Adjuvant Chemoradiation for Localized Gastric Adenocarcinoma: An Institutional Experience. J Cancer Sci Ther 9: 433-438. doi: 10.4172/1948- 5956.1000455

Copyright: © Touil A, Loughlimi H, Abbassi SEl, Echchikhi Y, Yatribi SAK, et al. (2017) Adjuvant Chemoradiation for Localized Gastric Adenocarcinoma: An Institutional Experience. J Cancer Sci Ther 9: 433-438. doi: 10.4172/1948- 5956.1000455

 

Abstract

cancer with locoregional relapse in 40% to 60%. The frequency of relapses makes regional radiotherapy an attractive possibility for adjuvant therapy. The survival benefit of adjuvant chemoradiation over surgery alone was first established by the US Intergroup 0116 study. Patients and methods: Between January 2010 and December 2014, 48 patients with localized gastric adenocarcinoma, managed at radiotherapy department of the national institut of oncology, they underwent adjuvant chemoradiation according the classical MacDonald regimen. Results: This series consisted of non-metastatic patients, 68.8% (33) males with a mean age 51 years. 20.8% (10) of patients had relapses (all distant relapse). 22 (45.8%) patients died, only 8(16.6%) patients were lost to follow up. Almost all patients complete full course chemoradiation. The median follow-up duration was 25.4 (15.6- 48) months. The 5 years OS and DFS was 40.8% and 49% respectively. Disease stage, operative procedure on primary tumor was an independent prognostic for both 5-year OS and DFS. The pN, surgical margin had a significant impact on OS. Conclusion: Adjuvant chemo-radiation may be an effective and safe regimen for patients who have undergone gastrectomy with curative intent in locally advanced stomach cancer and did not receive preoperative chemotherapy.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords